Astellas Sues Roxane Labs Over Generic Version of Billion-Dollar Cancer Drug Xtandi

Drug Industry Daily
A A
Astellas Pharma filed suit against generics makers Roxane Laboratories, West-Ward Pharmaceuticals and Hikma Pharmaceuticals over their copycat version of Xtandi.

To View This Article:

Login

Subscribe To Drug Industry Daily